Use the Laser Speckle Imaging System to measure blood flow in cerebral arteries via a cranial window in anesthetized mice, to corroborate an in vivo physiological role for pS1928 upon HG.

Share:

Martín-Aragón Baudel M, Flores-Tamez V A, Hong J, et al. Spatiotemporal control of vascular CaV1. 2 by α1c S1928 phosphorylation[J]. Circulation Research, 2022, 131(12): 1018-1033.

Journal: Circulation Research

Background and Customer Requirements:

  • 1) L-type CaV1.2 channels undergo cooperative gating to regulate cell function, although mechanisms are unclear.
  • 2) This study aim to test the hypothesis that phosphorylation of the CaV1.2 pore-forming subunit α-1C at S1928 mediates vascular CaV1.2 cooperativity during diabetic hyperglycemia.

Demands of the Research:

The main purpose of this study was to investigate the effect of phosphorylation of the CaV1.2 pore-forming subunit α-1C at S1928 mediates vascular CaV1.2 cooperativity. And it is crucial to get the blood flow to assess the effect.

What We Offer:

Product: RFLSI Laser Speckle Imaging System

Clear to see that representative pseudo-colored blood flow images of WT and S1928A cerebral pial arteries through a cranial window exposed to 10 mmol/L D-glu, 20 mmol/L D-glu or 0 Ca2+ vasodilatory mix, which confirms that pS1928 is necessary for increased arterial myocyte Ca2+ and contractility upon HG.

Results and Effects:

  • 1) CaV1.2 activity and cooperative gating increase in arterial myocytes from patients with type 2 diabetes and type 1 diabetic mice, and in wild-type mouse arterial myocytes after elevating extracellular glucose,which was prevented in wild-type cells pre-exposed to a PKA inhibitor or cells from knock-in S1928A but not S1700A mice.
  • 2) α-1C clustering at the surface membrane of wild-type, but not wild-type cells pre-exposed to PKA or P2Y11 inhibitors and S1928A arterial myocytes, was elevated upon hyperglycemia and diabetes.
  • 3) CaV1.2 spatial and gating remodeling correlated with enhanced arterial myocyte Ca2+ influx and contractility and in vivo reduction in arterial diameter and blood flow upon hyperglycemia and diabetes in wild-type but not S1928A cells/mice.
  • 4) The results may lay the foundation for developing therapeutics to correct CaV1.2 and arterial function during diabetic hyperglycemia.
  • Share

Have Any Questions?

Send Us A Message

  • 1.Fill in the form and our experts will get back to you ASAP!
  • 2.Ask about An Equipment
  • 3.Wondering which equipment to conduct your researches or perform your experiments? Our sales reps will try their best to share their knowledge with you!
  • 4.Get Technical Support
  • 5.An RWD equipment is not performing? Talk to our support team to get instant feedback!

Contact Us

Top
EMAIL

Contact Us